Currently, in addition to MLH1 and MSH2, whose testing was introduced in 1990s, mutations in the genes MSH6, PMS2, and EPCAM are now also included in testing of individuals suspected to have LS [57,58,59]. Here, PMS2 is linked to Leigh syndrome.